Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 5:18 AM
Ignite Modification Date:
2025-12-25 @ 5:18 AM
NCT ID:
NCT06225427
Brief Title:
Gilteritinib for the Treatment of ALK NSCLC
Official Title:
Phase I Study of Gilteritinib for ALK Positive Non-Small Cell Lung Cancer
Study:
NCT06225427
Protocol Section:
NCT06225427